Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alexander O Everhart, Ph.D.

Concepts (54)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Alexander Everhart's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Alexander Everhart has written about over time.
Diabetes Mellitus, Type 2, 2 publications between 2020 and 2021, average publication date September 2020. Hypolipidemic Agents, 2 publications between 2020 and 2021, average publication date September 2020. Fibric Acids, 1 publications between 2021 and 2021, average publication date February 2021. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2021 and 2021, average publication date February 2021. Drug Utilization, 2 publications between 2021 and 2021, average publication date May 2021. Medicare Part C, 2 publications between 2021 and 2021, average publication date May 2021. Practice Guidelines as Topic, 3 publications between 2021 and 2021, average publication date June 2021. Epoetin Alfa, 1 publications between 2021 and 2021, average publication date August 2021. Insurance, Health, 1 publications between 2021 and 2021, average publication date September 2021. Prescriptions, 1 publications between 2021 and 2021, average publication date September 2021. Amiodarone, 1 publications between 2021 and 2021, average publication date September 2021. Databases, Factual, 3 publications between 2020 and 2023, average publication date March 2022. Hypogonadism, 2 publications between 2021 and 2023, average publication date July 2022. Testosterone, 2 publications between 2021 and 2023, average publication date July 2022. United States Food and Drug Administration, 5 publications between 2021 and 2023, average publication date August 2022. Medical Device Recalls, 1 publications between 2023 and 2023, average publication date January 2023. Device Approval, 2 publications between 2023 and 2023, average publication date March 2023.

To see the data from this visualization as text, click here.
Everhart's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.